Divided government, as a result of Democrats taking back the House of Representatives in last week's election, means that almost all legislation will grind to a halt. This is especially true in today's era of political polarization.
But there is one Democratic policy priority that President Trump seems like he might support: prescription drug price controls. Last month, Trump introduced a new prescription drug pricing plan that would tie the prices of Medicare Part B drugs, which are administered in doctors' offices, to an International Pricing Index based on 16 other developed countries.
